# To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections

> **NCT00547417** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 1933 (actual)

## Conditions studied

- Impotence

## Interventions

- **DRUG:** tadalafil

## Key facts

- **NCT ID:** NCT00547417
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** 2004-03
- **Target enrollment:** 1933 (ACTUAL)
- **Last updated:** 2007-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00547417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00547417, "To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00547417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*